Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Action and Clinical Effect of BI 655130 in Patients With Fistulizing Crohn's Disease

NCT03752970 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03752970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Action and Clinical Effect of BI 655130 in Patients With Fistulizing Crohn's Disease
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
February 5, 2019
Completion date
July 4, 2022
Enrollment
27 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease